[1]王春平 刘增长.心房心肌病与不明原因栓塞性卒中的研究进展[J].心血管病学进展,2023,(6):524.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.010]
　WANG Chunping,LIU Zengzhang.Atrial Cardiomyopathy and Embolic Stroke of Undetermined[J].Advances in Cardiovascular Diseases,2023,(6):524.[doi:10.16806/j.cnki.issn.1004-3934.2023.06.010]
点击复制

心房心肌病与不明原因栓塞性卒中的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年6期
页码:
524
栏目:
综述
出版日期:
2023-06-25

文章信息/Info

Title:
Atrial Cardiomyopathy and Embolic Stroke of Undetermined
作者:
王春平 刘增长
(重庆医科大学附属第二医院心血管内科，重庆 400010）
Author(s):
WANG Chunping; LIU Zengzhang
(Department of Cardiologythe Second Affiliated Hospital of Chongqing Medical UniversityChongqing 400010China)
关键词:
心房心肌病; 心房心肌病标志物; 心房颤动; 栓塞性卒中; 不明原因栓塞性卒中【DOI】10.16806/j.cnki.issn.1004-3934.2023.06.000Advances in Atrial Cardiomyopathy and Embolic Stroke of Undetermined
Keywords:
Atrial cardiomyopathy;  Atrial cardiomyopathy markers;  Atrial fibrillation;  Embolic Stroke; Embolic stroke of undetermined source
DOI:
10.16806/j.cnki.issn.1004-3934.2023.06.010
摘要:
心房心肌病被定义为影响心房结构、形态、收缩或电生理特征，并导致心房重构、传导异常等相关表现的一类疾病。不明原因栓塞性卒中ESUS）是指通过标准卒中诊断流程仍未明确病因的一种特殊卒中亚型，它不包括腔隙性缺血性卒中。心房颤动是临床最常见的心律失常，约占缺血性卒中原因的，而栓塞性脑卒中是心房颤动最常见、最严重的并发症。最新研究表明，在无患者中，患有心房心肌病也可导致栓塞性卒中。因此，心房心肌病可能是ESUS的潜在机制。综述是基于已有的最新研究讨论心房心肌病的发病机制、标志物及其与ESUS之间的关系，旨在帮助解和识别心房心肌病与ESUS，从而加强在临床实践中对这些患者的管理。
Abstract:
Atrial cardiomyopathy is defined as a type of diseases that affects atrial structure,morphology,contraction,or electrophysiological characteristics and leads to associated manifestation such as atrial remodeling and conduction abnormalities. Embolic Stroke of Undetermined Source refers to a special stroke subtype whose etiology remains unidentified through standard stroke diagnostic procedures,and it does not include lacunar ischemic Stroke. Atrial Fibrillation is the most common arrhythmia in clinical practice,accounting for about one-third of the causes of ischemic stroke,and embolic stroke is the most common and serious complication of AF. Recent studies have shown that in patients without atrial fibrillation,having atrial cardiomyopathy can also lead to embolic stroke. Thus,atrial cardiomyopathy may be a potential mechanism for Embolic Stroke of Undetermined Source. This review discusses the pathogenesis,markers of atrial cardiomyopathy and their relationship with Embolic Stroke of Undetermined Source based one the latest available studies and aims to help us better understand and identify atrial cardiomyopathy and Embolic Stroke of Undetermined Source,thereby enhancing the management of these patients in clinical practice.

参考文献/References:

[1] Goette A,Kalman JM,Aguinaga L,et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies:definition,characterization,and clinical implication[J]. Europace,2016,18(10):1455-1490.

[[2] Goette A,Lendeckel U. Atrial cardiomyopathy:pathophysiology and clinical consequences[J]. Cells,2021,10(10):2605.

[[3] Li M,Ning Y,Tse G,et al. Atrial cardiomyopathy:from cell to bedside[J]. ESC Heart Fail,2022,9(6):3768-3784.

[[4] Ning Y,Tse G,Luo G,et al. Atrial cardiomyopathy:an emerging cause of the embolic stroke of undetermined source[J]. Front Cardiovasc Med,2021,8:674612.

[[5] Pezzo MP,Tufano A,Franchini M. Role of new potential biomarkers in the risk of thromboembolism in atrial fibrillation[J]. J Clin Med,2022,11(4):915.

[[6] Freedman B,Kamel H,Van Gelder IC,et al. Atrial fibrillation:villain or bystander in vascular brain injury[J]. Eur Heart J Suppl,2020,22(Suppl M):M51-M59.

[[7] Chen LY,Ribeiro ALP,Platonov PG,et al. P wave parameters and indices:a critical appraisal of clinical utility,challenges,and future research-a consensus document endorsed by the international society of electrocardiology and the international society for holter and noninvasive electrocardiology[J]. Circ Arrhythm Electrophysiol,2022,15(4):e010435.

[[8] Maheshwari A,Norby FL,Roetker NS,et al. Refining prediction of atrial fibrillation-related stroke using the P2-CHA2DS2-VASc score[J]. Circulation,2019,139(2):180-191.

[[9] Kreimer F,Aweimer A,Pflaumbaum A,et al. Impact of P-wave indices in prediction of atrial fibrillation-Insight from loop recorder analysis[J]. Ann Noninvasive Electrocardiol,2021,26(5):e12854.

[[10] Leung M,van Rosendael PJ,Abou R,et al. Left atrial function to identify patients with atrial fibrillation at high risk of stroke:new insights from a large registry[J]. Eur Heart J,2018,39(16):1416-1425.

[[11] Kuhnlein P,Mahnkopf C,Majersik JJ,et al. Atrial fibrosis in embolic stroke of undetermined source:a multicenter study[J]. Eur J Neurol,2021,28(11):3634-3639.

[[12] Shang L,Zhang L,Guo Y,et al. A review of biomarkers for ischemic stroke evaluation in patients with non-valvular atrial fibrillation[J]. Front Cardiovasc Med,2021,8:682538.

[[13] Ntaios G. Embolic stroke of undetermined source:JACC review topic of the week[J]. J Am Coll Cardiol,2020,75(3):333-340.

[[14] Kato Y,Takahashi S. Atrial cardiopathy and cryptogenic stroke[J]. Front Neurol,2022,13:839398.

[[15] Yoneda ZT,Anderson KC,Quintana JA,et al. Early-onset atrial fibrillation and the prevalence of rare variants in cardiomyopathy and arrhythmia genes[J]. JAMA Cardiol,2021,6(12):1371-1379.

[[16] Hart RG,Diener HC,Coutts SB,et al. Embolic strokes of undetermined source:the case for a new clinical construct[J]. Lancet Neurol,2014,13(4):429-438.

[[17] Sharma M,Smith EE,Pearce LA,et al. Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source:NAVIGATE ESUS MRI substudy[J]. Int J Stroke,2022,17(7):799-805.

[[18] Diener HC,Sacco RL,Easton JD,et al. Dabigatran for prevention of stroke after embolic stroke of undetermined source[J]. N Engl J Med,2019,380(20):1906-1917.

[[19] Sanna T,Diener HC,Passman RS,et al. Cryptogenic stroke and underlying atrial fibrillation[J]. N Engl J Med,2014,370(26):2478-2486.

更新日期/Last Update: 2023-07-21